Carta ao editor ouc omentário |
13 |
37,14 |
E1(1919 Gray AT, Boyles T, Luedtke S, Sossen B, Birjovanu G, Kostkova P, et al. A threat to decentralised care for drug-resistant tuberculosis. Lancet Respir Med. 2020;8(10):950-2. https://doi.org/10.1016/S2213-2600(20)30392-1 https://doi.org/10.1016/S2213-2600(20)30...
), E4(2020 Rawson TM, Ming D, Ahmad R, Mooree LSP, Holmes AH. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020;18:409–10. https://doi.org/10.1038/s41579-020-0395-y https://doi.org/10.1038/s41579-020-0395-...
), E7(44 Islam, M. Extensively Drug-Resistant Tuberculosis in the Time of COVID-19—How has the Landscape Changed for Pakistan? Disaster Medicine and Public Health Preparedness. 2020;14(4). https://doi.org/10.1017/dmp.2020.230 https://doi.org/10.1017/dmp.2020.230...
), E9(2121 Ndjeka N, Conradie F, Meintjes G, Reuter A, Hughes J, Padanilam X, et al. Responding to SARS- CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis? Eur Respir J. 2020;56(1):2001369. https://doi.org/10.1183/13993003.01369-2020 https://doi.org/10.1183/13993003.01369-2...
), E10(2222 Long Q, Huang, F, Huan, ST, Zhao YL. Scale-up of a comprehensive model to improve tuberculosis control in China: lessons learned and the way forward. Infect Dis Poverty. 2021;10(41). https://doi.org/10.1186/s40249-021-00828-1 https://doi.org/10.1186/s40249-021-00828...
), E13(1313 Coronel TR, Aguirre S, Pérez BD. Thinking about tuberculosis in times of COVID-19. J Intern Med. 2021 Apr;289(4):589-590. https://doi.org/10.1111/joim.13192 https://doi.org/10.1111/joim.13192...
), E14(2323 Mohr-Holland E, Douglas-Jones B, Apolis I, Ngambu N, Mathee S, Cariem R. Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic. Lancet Child Adolesc Health. 2021;5(3):159-61. https://doi.org/10.1016/S2352-4642(21)00003-1 https://doi.org/10.1016/S2352-4642(21)00...
), E15(2424 Migliori GB, Tiberi S, García-Basteiro AL, Duarte R. Tuberculosis and its future in the COVID- 19 era: the pulmonology series 2021. Pulmonology. 2021;27(2):94-6. https://doi.org/10.1016/j.pulmoe.2020.10.005 https://doi.org/10.1016/j.pulmoe.2020.10...
), E16(77 Buonsenso D, Iodice F, Biala JS, Goletti D. COVID-19 effects on tuberculosis care in Sierra Leone, Pulmonology. 2021;27(1):67-69. https://doi.org/10.1016/j.pulmoe.2020.05.013 https://doi.org/10.1016/j.pulmoe.2020.05...
), E17(2525 Meneguim AC, Rebello L, Das M, Ravi S, Mathur T, Mankar S, et al. Adapting TB services during the COVID-19 pandemic in Mumbai, India. Int J Tuberc Lung Dis. 2020;24(10):1119-21. https://doi.org/10.5588/ijtld.20.0537 https://doi.org/10.5588/ijtld.20.0537...
), E18(2626 Liu C, Yu Y, Fleming J, Wang T, Shen S, Wang Y, et al. Severe COVID-19 cases with a history of active or latent tuberculosis. Int J Tuberc Lung Dis. 2020;24(7):747-9. https://doi.org/10.5588/ijtld.20.0163 https://doi.org/10.5588/ijtld.20.0163...
), E21(2727 Mohr-Holland E, Hacking D, Daniels J, Scott V, Mudaly V, Furin J, et al. Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19. Int J Tuberc Lung Dis. 2021;25(9):772-5. https://doi.org/10.5588/ijtld.21.0340 https://doi.org/10.5588/ijtld.21.0340...
), E25(2828 Parums DV. Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis. Med Sci Monit. 2021;27:e934292. https://doi.org/10.12659/MSM.934292 https://doi.org/10.12659/MSM.934292...
) |
Revisões |
11 |
31,42 |
E2(1010 Stagg HR, Flook M, Martinecz A, Kielmann K, Wiesch PAZ, Karat AS, et al. All nonadherence is equal but is some more equal than others? tuberculosis in the digital era. ERJ Open Research. 2020;6(4):00315-2020. https://doi.org/10.1183/23120541.00315-2020 https://doi.org/10.1183/23120541.00315-2...
), E3(2929 Knight GM, Glover RE, McQuaid CF, Olaru ID, Galland K, Leclerc Q, et al. Antimicrobial resistance and COVID-19: intersections and implications. Epidemiol Glob Health. 2021;10:e64139. https://doi.org/10.7554/eLife.64139 https://doi.org/10.7554/eLife.64139...
), E6(1212 Allué-Guardia A, García JI, Torrelles JB. Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment. Frontiers in Microbiology. 2021;12. https://doi.org/10.3389/fmicb.2021.612675 https://doi.org/10.3389/fmicb.2021.61267...
), E8(3030 Tamuzi JL, Ayele BT, Shumba CS, Adetokunboh OO, Uwimana-Nicol J, Haile ZT, et al. Implications of COVID-19 in high burden countries for HIV/TB: a systematic review of evidence. BMC Infect Dis. 2020;744. https://doi.org/10.1186/s12879-020-05450-4 https://doi.org/10.1186/s12879-020-05450...
), E11(66 Migliori GB, Visca D, van den Boom M, Tiberi S, Silva DR, Centis R, et al. Tuberculosis, COVID-19 and hospital admission: consensus on pros and cons based on a review of the evidence. Pulmonology. 2021;27(3):248-56. https://doi.org/10.1016/j.pulmoe.2020.12.016 https://doi.org/10.1016/j.pulmoe.2020.12...
), E20(3131 Lobie TA, Roba AA, Booth JA, Kristiansen KI, Aseffa A, Skarstad K, et al Antimicrobial resistance: a challenge awaiting the post-COVID-19 era. Int J Infect Dis. 2021;111:322-5. https://doi.org/10.1016/j.ijid.2021.09.003 https://doi.org/10.1016/j.ijid.2021.09.0...
), E22(3232 Ramasamy P, Sounderrajan V, Vijayakumar KK, Harshavardhan S. Current Perceptions on Advanced Molecular Diagnostics for Drug-Resistant Mycobacterium tuberculosis. Biomed Pharmacol J. 2021;14(3). https://doi.org/10.13005/bpj/2226 https://doi.org/10.13005/bpj/2226...
), E24(3333 Wingfield T, Karmadwala F, MacPherson P, Millington KA, Walker NF, Cuevas LE, Squire SB. Challenges and opportunities to end tuberculosis in the COVID-19 era. Lancet Respir Med. 2021;9(6):556-8. https://doi.org/10.1016/S2213-2600(21)00161-2 https://doi.org/10.1016/S2213-2600(21)00...
), E28(88 Tiberi S, Vjecha MJ, Zumla A, Galvin J, Migliori GB, Zumla A. Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. Int J Infect Dis. 2021;113(Suppl-1):S96-S99. https://doi.org/10.1016/j.ijid.2021.02.067 https://doi.org/10.1016/j.ijid.2021.02.0...
), E31(3434 Caren GJ, Iskandar D, Pitaloka DAE, Abdulah R, Suwantika AA. COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia. J Multidiscip Healthc. 2022;15:175-83. https://doi.org/10.2147/JMDH.S341130 https://doi.org/10.2147/JMDH.S341130...
), E34(3535 du Preez K, Gabardo BMA, Kabra SK, Triasih R, Lestari T, Kal M, et al. Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low-and Middle-Income Countries. Pathogens. 2022;11(2):196. https://doi.org/10.3390/pathogens11020196 https://doi.org/10.3390/pathogens1102019...
) |
Qualitativo |
2 |
5,71 |
E27(3636 Souza LLL, Santos FLD, Crispim JA, Fiorati RC, Dias S, Bruce ATI, et al. Causes of multidrug - resistant tuberculosis from the perspectives of health providers: challenges and strategies for adherence to treatment during the COVID-19 pandemic in Brazil. BMC Health Serv Res. 2021;21(1):1033. https://doi.org/10.1186/s12913-021-07057-0 https://doi.org/10.1186/s12913-021-07057...
), E35(99 Santos FLD, Souza LLL, Bruce ATI, Crispim JA, Arroyo LH, Ramos ACV, et al. Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: a qualitative study. PLoS One. 2021;16(4):e0249822. https://doi.org/10.1371/journal.pone.0249822 https://doi.org/10.1371/journal.pone.024...
) |
Relato de caso |
3 |
8,57 |
E5(3737 Vilbrun SC, Mathurin L, Pape JW, Fitzgerald D, Walsh KF. Case Report: Multidrug-Resistant Tuberculosis and COVID-19 Coinfection in Port-au-Prince, Haiti. Am J Trop Med Hyg. 2020;103(5):1986-8. https://doi.org/10.4269/ajtmh.20-0851 https://doi.org/10.4269/ajtmh.20-0851...
), E26(3838 Marwah V, Peter DK, Ajai Kumar T, Bhati G, Kumar A. Multidrug-resistant tuberculosis in COVID-19: Double trouble. Med J Armed Forces India. 2021;77(Suppl-2):S479-S482. https://doi.org/10.1016/j.mjafi.2021.05.002 https://doi.org/10.1016/j.mjafi.2021.05....
), E30(3939 Yadav S, Rawal G. Primary multidrug-resistant pulmonary tuberculosis with a concomitant COVID-19 infection in an Indian female- World's first case of its type in this current pandemic. J Family Med Prim Care. 2021;10(10):3922-4. https://doi.org/10.4103/jfmpc.jfmpc_225_21 https://doi.org/10.4103/jfmpc.jfmpc_225_...
) |
Observacional descritivo |
3 |
8,57 |
E19(4040 Arega B, Negesso A, Taye B, Weldeyohhans G, Bewket B, Negussie T, et al. Impact of COVID-19 pandemic on TB prevention and care in Addis Ababa, Ethiopia: a retrospective database study. BMJ Open. 2022;12(2):e053290. https://doi.org/10.1136/bmjopen-2021-053290 https://doi.org/10.1136/bmjopen-2021-053...
), E23(4141 Kuchukhidze G, Yedilbayev A, Perehinets I, Schmidt T, Van Grinsven WL, Boeree MJ. Early COVID-19 pandemic’s toll on tuberculosis services, WHO European Region, January to June 2020. Euro Surveill. 2021;26(24):2100231. https://doi.org/10.2807/1560-7917.ES.2021.26.24.2100231 https://doi.org/10.2807/1560-7917.ES.202...
), E33(1111 Dean AS, Auguet OT, Glaziou P, Zignol M, Ismail N, Kasaeva T, et al. 25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward. Lancet Infect Dis. 2022;22(7):e191-e196. https://doi.org/10.1016/S1473-3099(21)00808-2 https://doi.org/10.1016/S1473-3099(21)00...
) |
Coorte retrospectiva |
2 |
5,71 |
E12(4242 Gajbhiye RK, Mahajan NN, Kamath N, Bahirat S, Patokar G, Bhurke AV, et al. Clinical presentations, pregnancy complications, and maternal outcomes in pregnant women with COVID-19 and tuberculosis: a retrospective cohort study. Int J Gynaecol Obstet. 2021;153(1):176-9. https://doi.org/10.1002/ijgo.13588 https://doi.org/10.1002/ijgo.13588...
), E32(55 Hasan T, Nguyen VN, Nguyen HB, Nguyen TA, Le HTT, Pham CD, et al. Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020. Emerg Infect Dis. 2022;28(3):684-92. https://doi.org/10.3201/eid2803.211919 https://doi.org/10.3201/eid2803.211919...
) |
Ecológico |
1 |
2,86 |
E29(4343 Gegia MI, Wares DF, Chadha SS, Mirzayev F. Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape. Int J Infect Dis. 2021;108:557-67. https://doi.org/10.1016/j.ijid.2021.06.022 https://doi.org/10.1016/j.ijid.2021.06.0...
) |
Total |
35 |
100 |
... |